血液透析中心静脉置管同侧影响同侧动静脉移植物结局
该回顾性队列研究基于退伍军人医院透析通路数据库(2014年5月至2018年4月),纳入71例上肢动静脉移植物(AVG)患者,其中55例(77%)中心静脉导管对侧置入,16例(23%)同侧置入。同侧组平均功能通畅时间350.94±431.23天,对侧组724.78±593.98天(P=0.001),同侧置管与功能通畅时间缩短相关(比值比0.25;P=0.03)。两组在置管成功率、血栓事件或总体血管内干预方面无差异。
要点
- 同侧中心静脉置管组AVG平均功能通畅时间350.94±431.23天,对侧组724.78±593.98天(P=0.001)。
- 既往中心静脉置管史及移植物位于导管同侧与功能通畅时间缩短相关(比值比0.25;P=0.03)。
- 两组在置管成功率、血栓事件或总体血管内干预方面无显著差异。
核心结论
- 在同侧中心静脉导管患者中,AVG功能通畅时间较对侧置管患者显著缩短。
- 同侧中心静脉置管似乎与AVG功能通畅时间缩短相关。
- 这些发现提示潜在的临床相关性差异,需要进一步研究。
研究设计与样本
- 回顾性队列研究,使用退伍军人医院透析通路数据库,时间范围为2014年5月至2018年4月。
- 共纳入71例上肢AVG患者,其中55例(77%)对侧置管,16例(23%)同侧置管。
- 所有结局随访至2021年7月,采用Student t检验、Fisher精确检验和多变量分析。
主要发现
- 同侧组100%(n=16)有既往中心静脉通路史,对侧组49.1%(n=27)(P<0.001)。
- 对侧组AVG平均功能通畅时间为724.78±593.98天,同侧组为350.94±431.23天(P=0.001)。
- 既往中心静脉置管史及移植物位于导管同侧与功能通畅时间缩短相关(比值比0.25;P=0.03)。
- 两组在置管成功率、血栓事件或总体血管内干预方面无显著差异。
关键数值与推荐
- 当前国家指南推荐中心静脉导管和AVG应置于现有血液透析通路的对侧。
- 同侧组既往中心静脉通路史比例为100%(n=16),对侧组为49.1%(n=27)(P<0.001)。
- 对侧组AVG平均功能通畅时间为724.78±593.98天,同侧组为350.94±431.23天(P=0.001)。
- 既往中心静脉置管史及移植物位于导管同侧与功能通畅时间缩短相关(比值比0.25;P=0.03)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需要进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Central venous stenosis is a common problem that diminishes vascular access lifespan. Current national guidelines recommend that central catheters and arteriovenous grafts (AVGs) be placed contralateral to an existing hemodialysis access. We set forth to delineate any clinically significant outcomes based on laterality in patients undergoing AVG placement with an existing central catheter for dialysis treatments. METHODS: Using a Veterans Administration Hospital dialysis access database over a four-year period (May 2014 to April 2018), we identified all patients who underwent AVG placement in an upper extremity with an existing ipsilateral (Ipsi-CL) or contralateral (Contra-CL) central line for hemodialysis. AVG outcomes examined included successful cannulation, functional patency, thrombosis events, and endovascular interventions per access site. Clinical records were also examined for location of AVG, arteriovenous fistula or AVG precursors, prior central line placement, peripherally inserted central catheter, and cardiac venous access. All outcomes were followed until July 2021. Student's t-test, Fisher's exact test, and multivariable analysis were used. RESULTS: A total of 71 AVGs: 55 (77%) were placed contralateral to existing central venous catheters and 16 (23%) were placed on the ipsilateral side. Baseline characteristics between the two groups were not found to be significantly different. This included a history of hypertension, smoking history, prior arteriovenous access, body mass index, race, glucose, creatinine, blood urea nitrogen, hemoglobin, mean corpuscular volume, platelet count, antiplatelet agent, and anticoagulation. 100% (n = 16) of patients in the Ipsi-CL group had previous central venous access compared to 49.1% (n = 27) in Contra-CL (P = <0.001). The mean functional patency for AVG with Contra-CL was 724.78 ± 593.98 days compared to AVGs with Ipsi-CL with mean days of 350.94 ± 431.23 days (P = 0.001). A history of previous central venous catheterization and graft on ipsilateral side of a catheter at the time of surgery was associated with decreased functional duration of graft (odds ratio, 0.25; P = 0.03). CONCLUSIONS: Within this cohort of patients that underwent AVG, we noted a statistically significant decrease in the duration of functional patency of grafts ipsilateral to central venous catheters. We did not find a difference in cannulation rates, thrombosis events, or overall endovascular interventions. Ipsilateral central access appears to be associated with decreased functional patency of AVGs. These findings highlight a discrepancy that is potentially clinically relevant and further studies are warranted.
引用
- Otoya D, Simmonds A, Lavingia K, et al. Central Line Access for Hemodialysis Adversely Affects Ipsilateral Arteriovenous Graft Outcomes. Ann Vasc Surg. 2022. PMID: 35577272. doi:10.1016/j.avsg.2022.04.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。